Table 1.
Demographic data and clinical information of included study
| Author | Sample size | Sex (M/F) | Diagnostic criteria | SZ age (mean±SD) | HC age (mean±SD) | Diagnosis | Drug state | Quanlity score |
|---|---|---|---|---|---|---|---|---|
| Shan et al. [22] | SZ 39 | 27/12 | DSM-5 | 24.64±5.01 | 25.7±4.9 | SZ | Yes | 9.5 |
| HC 20 | 14/6 | |||||||
| Zhao et al. [23] | SZ 44 | 31/13 | DSM-IV | 23.7±5.3 | 22.6±3.7 | FES | Drug naive | 10 |
| HC 26 | 17/9 | |||||||
| Zhang et al. [24] | SZ 53 | 42/11 | DSM-IV | 36.7±13.67 | 34.82±11.28 | SZ | Yes | 9.5 |
| HC 67 | 46/21 | |||||||
| Wang et al. [8] | SZ 48 | 21/27 | DSM-IV-TR | 15.79±1.64 | 15.42±1.52 | FES | Drug naive | 10 |
| HC 31 | 14/17 | |||||||
| Gou et al. [25] | SZ 28 | 16/12 | DSM-IV | 23.9±5.4 | 28.8±6.1 | SZ | Yes | 9.5 |
| HC 21 | 14/7 | |||||||
| Gao et al. [27] | SZ 34 | 19/15 | DSM-IV | 35.13±8.85 | 32.73±7.61 | SZ | Yes | 10 |
| HC 29 | 16/13 | |||||||
| Liu et al. [11] | SZ 27 | 15/12 | DSM-IV | 25.44±5.92 | 27.44±7.24 | SZ | Partly | 9.5 |
| HC 27 | 18/9 | |||||||
| Cui et al. [28] | SZ 32 | NA | DSM-IV-TR | NA | NA | FES | Drug naive | 9 |
| HC 19 | ||||||||
| Gao et al. [26] | SZ 14 | 9/5 | DSM-IV | 33.2±10.7 | 34.9±113.6 | SZ | Yes | 9.5 |
| HC 14 | 9/5 | |||||||
| Yu et al. [9] | SZ 69 | 34/35 | DSM-IV | 31.7±9.6 | 29.9±8.6 | SZ | Yes | 9.5 |
| HC 62 | 25/27 | |||||||
| Liu et al. [12] | SZ 18 | 9/9 | DSM-IV | 23.67±4.397 | 24.44±3.884 | SZ | Yes | 9 |
| HC 18 | 9/9 | |||||||
| Chen et al. [30] | SZ 36 | 16/20 | DSM-IV | 28.28±1.43 | 35.68±1.81 | SZ | Yes | 9 |
| HC 44 | 17/27 | |||||||
| Yan et al. [29] | SZ 69 | 50/19 | DSM-IV | 24.22±7.08 | 26.27±6.97 | FES | Drug naive | 10 |
| HC 74 | 45/29 |
SZ: schizophrenia, FES: first-episode schizophrenia, HC: healty control, NA: not available, SD: standard deviation, M: male, F: female, DSM: Diagnostic and Statistical Manual of Mental Disorders